Glancy Prongay & Murray LLP Reminds Investors of Upcoming Deadline in Class Action Lawsuit Against Methode Electronics, Inc. (MEI) Page 1

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 25, 2024 Deadline for filing a lead plaintiff motion in the class action lawsuit on behalf of investors who purchased common stock of Methode Electronics, Inc. (“Methode” or the “Company”) (NYSE: MEI) between 23 June 2022 and 6 March 2024inclusive (the “Lesson”).

If you have suffered a loss on your Methode investments or would like to learn about the possibility of recovering your loss under the federal securities laws, you may submit your contact information at www.glancylaw.com/cases/Methode-Electronics-Inc/. You may also contact Charles H. Linehan of GPM at 310-201-9150, toll-free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On March 9, 2023, Methode released its financial results for the third quarter of fiscal 2023 and lowered its 2023 diluted earnings per share forecast. Analysts speculated that the miss was due to “delays in customers ramping up production.” Following this news, Methode's share price fell $6.21, or 13.1%, to close at $41.36 per share on March 13, 2023, hurting investors.

On June 12, 2023, Methode then released its preliminary financial results for 2023, stating that the company expected below-range annual earnings per share and lower-than-expected net revenue and diluted earnings per share, “due to, among other things, additional costs to support new program launches and the impact of program roll-offs.” On June 22, 2023, Methode announced its fourth quarter and full-year 2023 financial results, reporting net revenue that was below the preliminary results previously provided. On this news, Methode's share price fell $12.30, or 27.3%, closing at $32.77 per share on June 23, 2023.

On September 7, 2023, Methode released its financial results for the first quarter of fiscal 2024, stating that “operational inefficiencies” in the Company's North American operations and increased expenses related to the launch of new programs negatively impacted the quarter's results and were expected to continue into the second quarter. The Company also lowered its expectations for net sales and diluted earnings per share for 2024. On this news, Methode's share price fell $6.67, or 22.2%, to close at $23.33 per share on September 7, 2023.